MedTrace Logo

Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia

NCT02325063 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-12-10

No results posted yet for this study

Summary

The primary objective of this study is to compare the evolution of pain profiles among patients suffering from lateral epicondyalgia (tennis elbow) following three types of treatment: PRP-L injection versus type A botulinum toxin injection versus corticoid injection.

Conditions

  • Epicondylitis, Lateral Humeral
  • Tennis Elbow

Interventions

DRUG

PRP-L Injection

Patients will be treated with an injection of leukocyte and platelet rich plasma.

DRUG

Botox injection

Patients will be treated with an injection of Type A Botulinum toxin.

DRUG

Corticoid injection

Patients will be treated with an injection of Corticoids.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Matthieu Vaucher, MD · Centre Hospitalier Universitaire de Nîmes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-17
Primary Completion
2017-05-02
Completion
2017-05-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02325063 on ClinicalTrials.gov